<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Secondary <z:hpo ids='HP_0003077'>hyperlipidemia</z:hpo> is a major <z:e sem="disease" ids="C0850624" disease_type="Disease or Syndrome" abbrv="">cardiovascular risk factor</z:e> in individuals with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Increased hepatic production of <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> B (apoB)-containing <z:chebi fb="2" ids="6495">lipoproteins</z:chebi> contributes to the elevated plasma levels, but the mechanism is poorly understood </plain></SENT>
<SENT sid="2" pm="."><plain>Recent results have established that microsomal <z:chebi fb="0" ids="17855">triglyceride</z:chebi> transfer protein (MTP) is rate limiting for the assembly and secretion of apoB-containing <z:chebi fb="2" ids="6495">lipoproteins</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>To better understand the mechanism of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>-associated <z:hpo ids='HP_0003077'>hyperlipidemia</z:hpo>, we quantified hepatic MTP <z:chebi fb="2" ids="33699">mRNA</z:chebi> levels, hepatic microsomal <z:chebi fb="0" ids="17855">triglyceride</z:chebi> transfer activity, and in vivo <z:chebi fb="0" ids="17855">triglyceride</z:chebi> secretion from the liver in two diabetic mouse models </plain></SENT>
<SENT sid="4" pm="."><plain><z:mp ids='MP_0001261'>Obese</z:mp> diabetic (ob/ob) mice had 45% higher (P = 0.006) hepatic MTP <z:chebi fb="2" ids="33699">mRNA</z:chebi> levels, 54% higher (P &lt; 0.0001) microsomal <z:chebi fb="0" ids="17855">triglyceride</z:chebi> transfer activity, and 70% higher (P &lt; 0.0001) in vivo <z:chebi fb="0" ids="17855">triglyceride</z:chebi> secretion rates compared with ob/+ control mice </plain></SENT>
<SENT sid="5" pm="."><plain>In contrast, in lean <z:chebi fb="1" ids="9288">streptozotocin</z:chebi>-treated diabetic mice, hepatic MTP <z:chebi fb="2" ids="33699">mRNA</z:chebi> levels were unchanged, whereas microsomal <z:chebi fb="0" ids="17855">triglyceride</z:chebi> transfer activity and in vivo <z:chebi fb="0" ids="17855">triglyceride</z:chebi> secretion rates were marginally decreased </plain></SENT>
<SENT sid="6" pm="."><plain>These studies suggest that <z:hpo ids='HP_0001513'>obesity</z:hpo>-induced type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> in mice confers increases in hepatic MTP expression and secretion of <z:chebi fb="0" ids="17855">triglyceride</z:chebi>-rich <z:chebi fb="2" ids="6495">lipoproteins</z:chebi> </plain></SENT>
<SENT sid="7" pm="."><plain>High blood <z:chebi fb="105" ids="17234">glucose</z:chebi> and altered hepatic expression of <z:chebi fb="0" ids="15889">sterol</z:chebi> regulatory element binding protein genes play a minor role in this diabetic response </plain></SENT>
</text></document>